Hemab Therapeutics Holdings, Inc. · NASDAQ:COAG

Shah Rajeev M. bought 2,840,429 Hemab Therapeutics Holdings, Inc. shares (Form 4)

Traded May 4 to May 6, 2026 · Filed May 6, 2026

From May 4 to May 6, 2026, Shah Rajeev M. (Director, 10% owner) bought 2,840,429 Hemab Therapeutics Holdings, Inc. shares at an average US$18.39 for US$52.2M, leaving 6,314,525 shares. Filed May 6, 2026 (Form 4).

Bought
2,840,429 shares
Price
US$18.39 average (US$18.00 to US$25.00)
Value
US$52.2M
Holding after
6,314,525 shares (held indirectly)
Trading plan
No
Role
Director, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 4, 2026Common StockConversion3,607,8463,607,846Indirect
May 4, 2026Common StockConversion1,009,0521,009,052Indirect
May 4, 2026Common StockConversion221,188221,188Indirect
May 4, 2026Common StockBuy2,541,250US$18.006,149,096Indirect
May 4, 2026Common StockBuy133,750US$18.00354,938Indirect
May 5, 2026Common StockBuy87,143US$24.596,236,239Indirect
May 5, 2026Common StockBuy10,268US$25.006,246,507Indirect
May 6, 2026Common StockBuy14,611US$23.776,261,118Indirect
May 6, 2026Common StockBuy53,407US$24.836,314,525Indirect

Source

View original at SEC

Related